KDR and hepatocellular carcinoma: This study gave a convincing evidence to demonstrate that hSulf-1 re-expression both in ovarian and hepatocellular cancer cells attenuates the phosphorylation of VEGFR-2, then suppresses cancer cell proliferation and angiogenesis, finally induces antitumor efficacy.